185 related articles for article (PubMed ID: 38238718)
1. Factors associated with cellulitis in lymphoedema of the arm - an international cross-sectional study (LIMPRINT).
Burian EA; Franks PJ; Borman P; Quéré I; Karlsmark T; Keeley V; Sugama J; Cestari M; Moffatt CJ
BMC Infect Dis; 2024 Jan; 24(1):102. PubMed ID: 38238718
[TBL] [Abstract][Full Text] [Related]
2. Cellulitis in chronic oedema of the lower leg: an international cross-sectional study.
Burian EA; Karlsmark T; Franks PJ; Keeley V; Quéré I; Moffatt CJ
Br J Dermatol; 2021 Jul; 185(1):110-118. PubMed ID: 33405247
[TBL] [Abstract][Full Text] [Related]
3. LIMPRINT: Estimation of the Prevalence of Lymphoedema/Chronic Oedema in Acute Hospital in In-Patients.
Quéré I; Palmier S; Noerregaard S; Pastor J; Sykorova M; Dring E; Franks PJ; Murray S; Keeley V; Bermark S; Karlsmark T; Kyne N; Colgan MP; Coulombe MM; Mestre S; Mercier G; Moffatt CJ
Lymphat Res Biol; 2019 Apr; 17(2):135-140. PubMed ID: 30995191
[No Abstract] [Full Text] [Related]
4. LIMPRINT: The UK Experience-Subjective Control of Swelling in Patients Attending Specialist Lymphedema Services.
Moffatt CJ; Keeley V; Hughes A; Clark K; Lisle J; Benson M; Gaskin R; Sykorova M; Dring E; Murray S; Mercier G; Quere I; Franks PJ
Lymphat Res Biol; 2019 Apr; 17(2):211-220. PubMed ID: 30995196
[No Abstract] [Full Text] [Related]
5. Association Between Access to Specialists and History of Cellulitis Among Patients with Lymphedema: Secondary Analysis Using the National LIMPRINT Database.
Dai M; Nakagami G; Sato A; Koyanagi H; Kohta M; Moffatt CJ; Murray S; Franks PJ; Sanada H; Sugama J
Lymphat Res Biol; 2021 Oct; 19(5):442-446. PubMed ID: 34582714
[No Abstract] [Full Text] [Related]
6. LIMPRINT Study: The Turkish Experience.
Borman P; Moffatt C; Murray S; Yaman A; Denizli M; Dalyan M; Unsal-Delialioğlu S; Eyigör S; Ayhan F; Çakıt BD; Vural S; Özdemir O; Kurt E; Çelik EC; Cerrahoğlu L; Kepekçi M; Terzioğlu F; Donmez AA
Lymphat Res Biol; 2019 Apr; 17(2):202-210. PubMed ID: 30995192
[No Abstract] [Full Text] [Related]
7. LIMPRINT in Specialist Lymphedema Services in United Kingdom, France, Italy, and Turkey.
Keeley V; Franks P; Quere I; Mercier G; Michelini S; Cestari M; Borman P; Hughes A; Clark K; Lisle J; Benson M; Noerregaard S; Karlsmark T; Murray S; Moffatt C
Lymphat Res Biol; 2019 Apr; 17(2):141-146. PubMed ID: 30995195
[No Abstract] [Full Text] [Related]
8. The Prevalence and Functional Impact of Chronic Edema and Lymphedema in Japan: LIMPRINT Study.
Dai M; Nakagami G; Sugama J; Kobayashi N; Kimura E; Arai Y; Sato A; Mercier G; Moffatt C; Murray S; Sanada H
Lymphat Res Biol; 2019 Apr; 17(2):195-201. PubMed ID: 30995194
[No Abstract] [Full Text] [Related]
9. Wounds in chronic leg oedema.
Burian EA; Karlsmark T; Nørregaard S; Kirketerp-Møller K; Kirsner RS; Franks PJ; Quéré I; Moffatt CJ
Int Wound J; 2022 Feb; 19(2):411-425. PubMed ID: 34258856
[TBL] [Abstract][Full Text] [Related]
10. Interventions for the prevention of recurrent erysipelas and cellulitis.
Dalal A; Eskin-Schwartz M; Mimouni D; Ray S; Days W; Hodak E; Leibovici L; Paul M
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009758. PubMed ID: 28631307
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with melanoma-related limb lymphoedema.
Gjorup CA; Dahlstroem K; Hendel HW; Drzewiecki KT; Klausen TW; Hölmich LR
Acta Oncol; 2021 Jun; 60(6):779-784. PubMed ID: 33793386
[TBL] [Abstract][Full Text] [Related]
12. Surgical interventions for the prevention or treatment of lymphoedema after breast cancer treatment.
Markkula SP; Leung N; Allen VB; Furniss D
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD011433. PubMed ID: 30779124
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for developing upper limb cellulitis after breast cancer treatment.
Engin O; Sahin E; Saribay E; Dilek B; Akalin E
Lymphology; 2022; 55(2):77-83. PubMed ID: 36170582
[TBL] [Abstract][Full Text] [Related]
14. Conservative interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapy.
Stuiver MM; ten Tusscher MR; Agasi-Idenburg CS; Lucas C; Aaronson NK; Bossuyt PM
Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD009765. PubMed ID: 25677413
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of the efficacy of vascularised lymph node transfer in reducing limb volume and cellulitis episodes in patients with cancer treatment-related lymphoedema.
Ward J; King I; Monroy-Iglesias M; Russell B; van Hemelrijck M; Ramsey K; Khan AA
Eur J Cancer; 2021 Jul; 151():233-244. PubMed ID: 34092349
[TBL] [Abstract][Full Text] [Related]
16. Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study.
Vignes S; Dupuy A
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):818-22. PubMed ID: 16898904
[TBL] [Abstract][Full Text] [Related]
17. Arm lymphoedema in a cohort of breast cancer survivors 10 years after diagnosis.
Johansson K; Branje E
Acta Oncol; 2010; 49(2):166-73. PubMed ID: 20100154
[TBL] [Abstract][Full Text] [Related]
18. [Lymphedema after breast carcinoma. A study of 5868 cases].
Schünemann H; Willich N
Dtsch Med Wochenschr; 1997 Apr; 122(17):536-41. PubMed ID: 9190300
[TBL] [Abstract][Full Text] [Related]
19. Associations between the treatments and outcomes of patients with upper and lower lymphoedema in Japan: a cross-sectional observational study.
Iuchi T; Dai M; Sanada H; Okuwa M; Nakatani T; Sugama J
Int J Nurs Stud; 2015 May; 52(5):913-9. PubMed ID: 25769476
[TBL] [Abstract][Full Text] [Related]
20. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.
DiSipio T; Rye S; Newman B; Hayes S
Lancet Oncol; 2013 May; 14(6):500-15. PubMed ID: 23540561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
